Bexarotene-induced hypothyroidism and dyslipidemia; a nation-wide study

Central hypothyroidism and dyslipidemia are well-known adverse events (AEs) of bexarotene therapy. Although hypothyroidism is known to cause dyslipidemia, no study has examined the association between hypothyroidism and dyslipidemia in patients undergoing bexarotene therapy. The aim of this study is...

Full description

Saved in:

Bibliographic Details
Main Authors:	Katsunori Manaka, Junichiro Sato, Yusuke Hikima, Hirofumi Horikoshi, Maho Taguchi, Akimichi Morita, Hiraku Suga, Hikari Boki, Taku Fujimura, Yoji Hirai, Takatoshi Shimauchi, Chiharu Tateishi, Eiji Kiyohara, Ikko Muto, Hideki Nakajima, Riichiro Abe, Kazuyasu Fujii, Chikako Nishigori, Eiji Nakano, Kentaro Yonekura, Takeru Funakoshi, Masahiro Amano, Tomomitsu Miyagaki, Reiko Yamashita, Makoto Sugaya, Toshihisa Hamada, Masaomi Nangaku, Taroh Iiri, Noriko Makita
Format:	Article
Language:	English
Published:	The Japan Endocrine Society 2024-08-01
Series:	Endocrine Journal
Subjects:	bexarotene hypothyroidism dyslipidemia hypertriglyceridemia
Online Access:	https://www.jstage.jst.go.jp/article/endocrj/71/8/71_EJ23-0699/_html/-char/en
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Bexarotene-induced hypothyroidism and dyslipidemia; a nation-wide study

Similar Items